Navigation Links
Encorium Reports Fourth Quarter and Full Year 2008 Financial Results
Date:4/27/2009

h interim asset impairment charge recorded by the Company during the third quarter of 2008 as well as the $12.5 million charge taken in the fourth quarter.

Financial Position

Encorium's balance sheet at December 31, 2008 reflected cash and cash equivalents of $5.7 million and shareholders' equity of $4.2 million. The Company has no outstanding debt. The Company's latest financials have been prepared on a going concern basis. The Company anticipates it will be able to meet its cash requirements through March 2010 assuming it is able to fully implement its cost cutting initiatives, win additional contracts during fiscal 2009 and maintain current customer contracts. If the Company is unable to do this, in order to remain a going concern it will be required to obtain additional capital or significantly reduce operating costs, which may include the cessation of operations in some countries.

About Encorium Group, Inc.

Encorium Group, Inc. is a global clinical research organization specializing in the design and management of complex clinical trials and Patient Registries for the pharmaceutical, biotechnology and medical device industries. The Company's mission is to provide its clients with high quality, full-service support for their biopharmaceutical and medical device development programs. Encorium offers therapeutic expertise, experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical trial experience across a wide variety of therapeutic areas such as infectious diseases, cardiovascular, vaccines, oncology, diabetes endocrinology/metabolism, gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. Encorium believes that its expertise in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its applicati
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing
2. Encorium Appoints Shahab Fatheazam to its Board of Directors
3. Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Remuda Ranch Reports Eating Disorders on the Rise Among Elderly
6. HCA Reports First Quarter 2009 Results
7. Recent Study Disproves General Hospitals Ongoing Criticism of Physician Owned Hospitals, Shows Little to No Effect on General Hospitals Business, Reports Physician Hospitals of America
8. Neovasc Inc. Reports Year 2008 Financial Results
9. NBTY Reports Second Quarter Results
10. Statement from USPA Exec. Dir. on News Reports of Florida Pharmacy Admission of Error in the Medicine Dispensed to the Horses Who Died on Sunday
11. Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... Patients who undergo radiation for a ... in life, but the disease is likely to differ ... to radiation. Surviving Mesothelioma has just posted the details ... here to read it now. , Scientists from ... 45 patients who had both a hematologic cancer (like ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... April 18, 2015 “ ArcAngel ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... personal safety app. , In a turbulent world, people ... Calling 911 should always be their first move, but some ...
(Date:4/17/2015)... 18, 2015 Heritage Woods of McLeansboro, ... Supportive Living Week Celebration on April 20 with a ... healthy mind, body and soul. , The community, which ... serves older adults of all incomes, including those on ... , Supportive Living Week is observed every April and ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... syndrome (BCS) results from hepatic venous outflow obstruction,at ... atrium. Few patients respond to,medical treatment (anticoagulation ... to restore the hepatic blood flow. Restoring outflow ... balloon dilatation stenting is the management of ...
... TUESDAY, March 15 (HealthDay News) -- Guidelines for children,s ... updated, say researchers who reviewed 69 studies that included ... produced new reference ranges that differ widely from existing ... University in the United Kingdom, and colleagues. The reference ...
... March 14 If all eligible patients filled their prescriptions ... amount to nearly $6 billion, according to a University of ... the March 14 issue of Archives of Internal Medicine ... national savings from a broad use of discounted generic medication ...
... Heavy alcohol consumption, specifically three or more glasses ... risk of death from pancreatic cancer, according to a ... of Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay ... breast cancer, tamoxifen can protect against the disease for ... medical costs, new research suggests. For years, women ... tamoxifen as a preventive measure. But previous cost-effectiveness research ...
... , MONDAY, March 14 (HealthDay News) -- Women may ... a diet rich in two types of B vitamins, a ... and riboflavin (B2) in their food significantly reduced their risk ... fortified cereals, whole grains, beans and nuts, and researchers said ...
Cached Medicine News:Health News:Updates Urged for Kids' Heart, Breathing Rate Guidelines 2Health News:Use of $4 generic drug programs could save society billions of dollars, study shows 2Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 3Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2
(Date:4/17/2015)... , April 17, 2015 Contego Medical, ... Embolic Protection™ filter platform for angioplasty balloon and ... $5.6 million Series B financing round led by ... with a focus on medical devices, biopharmaceuticals, diagnostics ... also included Mountain Group Partners, Lookout Capital and ...
(Date:4/17/2015)... MINNEAPOLIS , April 17, 2015 Nonin ... announced that President and Chief Operating Officer Steve ... Philip Isaacson is expanding his role as Chief ... his role as Chief Technology Officer. Operations will transition ... " Steve Bucholz has been instrumental to ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has announced ... Strategic Business Report" report to their offering. ... Testing in US$ Million by the following Segments: Toxicology ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... Reportlinker.com announces that a new market ... Depression Therapeutics - Pipeline ... http://www.reportlinker.com/p0656880/Depression-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
... LAKE, N.J., Oct. 14, 2011 Par Pharmaceutical, Inc., ... PRX ) today announced that it filed ... injunction in U.S. District Court in Washington, D.C. seeking ... information to physicians and other healthcare providers about the ...
Cached Medicine Technology:Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 2Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 3Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 4
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... The AVOXimeter 4000 provides a fast, ... bedside. The AVOXimeters patented,state-of-the-art optics yield ... as well as total hemoglobin. When,used ... analyzer, the AVOXimeter,4000 gives a comprehensive ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: